Have a question?
Please get in touch with our team in case of any queries
FERTILITY TEST MARKET WAS VALUED AT USD 440 MILLION IN 2021 AND IS EXPECTED TO REACH USD 660 MILLION BY 2027, GROWING AT A CAGR OF 7% DURING THE PERIOD 2022-2027.
Fertility Test Market Size, Share, & Trends Analysis Report by
- Products - Ovulation Test Kits, Fertility Monitors, and Sperm Test Kit
- Gender - Male and Female
- Distribution Channel - Online Sale Channels, Retail Pharmacies, and Hospital Pharmacies
- End-Users - Homecare, Speciality and Fertility Clinics, and Hospitals
- Geography - North America, Europe, APAC, Latin America, and the Middle East and Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
FERTILITY TEST MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| MARKET SIZE (REVENUE) | USD 659.71 BILLION (2027) |
| CAGR (REVENUE) | 7% (2022-2027) |
| BASE YEAR | 2021 |
| FORECAST PERIOD | 2022 – 2027 |
| MARKET SEGMENTS | Products (Ovulation Test Kits, Fertility Monitors, and Sperm Test Kit), Gender (Male and Female), Distribution Channel (Online Sale Channels, Retail Pharmacies, and Hospital Pharmacies), End-Users (Homecare, Speciality and Fertility Clinics, and Hospitals) |
| GEOGRAPHICAL ANALYSIS | North America, Europe, APAC, Latin America and Middle East and Africa |
| COUNTRIES COVERED | US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa |
REPORT OVERVIEW
The global fertility test market was valued at USD 439.56 million in 2021 and is expected to reach USD 659.71 million by 2027, growing at a CAGR of 7%. The global fertility treatment is presumably to grow at a healthy rate due to attractive long-term growth from favorable demographic and social/cultural shifts. Fertility testing is a niche industry with high margins for manufacturers, especially for vendors offering kits, which males and females widely use.
Over the past few years, the fertility test industry has been growing at a healthy rate because of rising awareness regarding fertility testing, increasing maternal age of women in developed and developing regions, rapidly increasing infertility population across the globe, and awareness among the adult population. On average, infertility affects 10% to 25% of all reproductive-age couples. This increase in the prevalence of infertility among both men and women is expected to drive the global fertility test market.
KEY HIGHLIGHTS
- Females are the major contributor to growth. Vendors can focus on female fertility test products with various promotional strategies such as advertising with celebrities to boost the global Fertility Test Market growth.
- In 2020, the healthcare industry introduced a new technology known as the 'Cap-Score' test, designed and developed to address information about men's fertility.
- In 2018, the era was to start with the development of the smartphone-based ovulation and fertility test came in the application. This evolution done in Brigham Women's Hospital developed low-cost & automated tools for ovulation tests for women preferring family planning which can fuel the market growth.
- As per the PubMed 2016 on fertility awareness and knowledge in women, fertility awareness among women increasing rapidly in recent years. Around 37.5% of study respondents were highly active in acquiring an understanding of fertility awareness, and 9.8% tried to understand the pregnancy about knowledge.
THIS RESEARCH REPORT INCLUDES A DETAILED ANALYSIS BY:
- Products
- Gender
- Distribution Channel
- End-Users
SEGMENTATION ANALYSIS
- The rising demand for unwanted pregnancies has increased the usage of fertility monitor devices. Fertility monitor devices are helpful for analyzing the menstrual cycle and other parameters related to fertility. Most of the time the acceptance of fertility monitors devices for analyzing the fertility of being pregnant and sometimes for avoiding the pregnancy, eventually driving the fertility testing devices market.
- Technology advancement is one of the major factors surging industry growth. Fertility monitoring devices are available as connected devices with smartphones and various application gives easy access, which drives the application rate of the fertility monitors devices.
- The high prevalence of fertility across the globe and first-time pregnancy are the major factors that demand the detection of luteinizing hormone (LH) surge, where ovulation test kits play a vital role. The rising number of pregnancies and fertility accelerate the growth of the ovulation test product segment.
- The increasing number of hospital and hospital visits for fertility-related issues and consultations for the application of fertility test kits. Hospital-associated pharmacies have derived awareness about fertility test kits with various mediums that positively influence the growth. Increasing the number of gynecologists and obstetricians and consultation services fuel the growth and demand of the fertility testing market.
VENDOR ANALYSIS
- In October 2021, Everly health of fertility test kit manufacturing company, acquired the fertility Startup Natalist. The Ro digital elective care company acquired modern fertility in June 2021 and home sperm storage start-up Dadi.
- The fertility test kit manufacturer is trying to achieve a high market share with different revenue generation strategies. Some sperm test kit manufacturing companies include swim count, advacare, DNA Diagnostics Centre, Hamilton Thorne, Home Health, Give Legacy. These companies deliver high-quality sperm test kits in domestic and international markets and will achieve a higher share in the upcoming time in the fertility test market.
- As there is an increasing shift from analog testing to digital testing to meet the growing demands, manufacturers are investing in the research and development of more innovative devices for ovulation prediction and fertility testing kits. The digital strip reader is currently used for pregnancy prediction and is anticipated to have expanded use of infertility testing and ovulation testing soon.
- New start-ups and product launches maintain competitiveness in the market. Most of the start-ups came up with new products and software-based smartphone applications which will create new competition for male fertility testing product kits. Moreover, Legacy, a start-up, came up with sperm freezing and analytics; however, India-based Inito launched a portable ovulation test kit to accelerate the growth of the fertility test market.
GEOGRAPHICAL ANALYSIS
- North America accounts for 6% in taking advice for a fertility test whereas, in Europe, the increasing consultation for fertility growth accounted for a 9% rise in the market. Rising hospitals across the Asian countries & female visits regarding fertility problems showed a decrease of fertility issues across the globe.
- Around 11% of North American women and 9% of men experience the fertility problem. Moreover, in the United States, 9% of men and 10% of women between the age group 15-44 years suffer from infertility problems which positively influence the market growth by driving demand for the fertility test. According to Arizton Advisory & Intelligence, the U.S. fertility test market is expected to grow at a CAGR of 7% from 2022-2027.
- In Europe, around 9% increment accounted for fertility consultation by professionals. Rising prostate cancer and testicle cancer, decreasing sperm count in males, increasing consumption of alcohol, and smoking are the factors that drive infertility in males. The overall population has high trust in the fertility experts propelling the growth of the consultation about fertility problems in European couples.
- Decreasing population and rising demand for fertility tests, and rising demand for consultation related to reproductive system issues in females are the major factors fueling the market growth in China. However, the fertility rate of Japan in 2021 is 1.3 births per woman, which is a decline from 2020 by 0.07%. Around 34% of the women population suffer from fertility-related problems that triggered the market growth in Japan.
The fertility test market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Products
- Ovulation Test Kits
- Fertility Monitors
- Sperm Test Kit
By Gender
- Male
- Female
By Distribution Channel
- Online Sale Channels
- Retail Pharmacies
- Hospital Pharmacies
By End-Users
- Homecare
- Speciality and Fertility Clinics
- Hospitals
By Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
SNAPSHOT
The fertility test market by revenue is expected to grow at a CAGR of around 7% during the period 2022–2027.
THIS REPORT ADDRESSES:
- The technological advancement in fertility Tests
- Smartphone-based Sample Analysis
- Increasing maternal age
- The growing rate of infertility test
- Growing awareness about fertility tests and greater access to treatment
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the fertility test market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and Fertility test market trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
PROMINENT VENDORS
- AB Analitica
- Business Overview
- Product Offerings
- Ava AG
- Advacare Pharma
- Babystart Ltd.
- Biozhena
- Cyclotest
- DNA Diagnostics Center
- Give Legacy Inc
- Exseed Health
- Lady Technologies
- Fertility Focus limited
- Femometer
- Fairhaven Health
- Geratherm Medical
- Hilin Life Products Inc
- iXensor
- LetsGetChecked
- Medical Electronic System
- Modern Fertility
- OOVA
- Piramal Pharma
- Premom
- Raiing Medical
- Samplytics Technologies
- SwimCount
- Swiss Precision Diagnostics
- Teco Diagnostics
- Yesmom
- Valley Electronics AG
Market Segmentation by Products
- Ovulation Test Kits
- Fertility Monitors
- Sperm Test Kit
Market Segmentation by Gender
- Male
- Female
Market Segmentation by Distribution Channel
- Online Sale Channels
- Retail Pharmacies
- Hospital Pharmacies
Market Segmentation by End-Users
- Homecare
- Speciality and Fertility Clinics
- Hospitals
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
Frequently Asked Questions
What is the size and growth rate in the fertility test market during the forecast period?
Who are the key players in the fertility test market?
What are the major growth drivers that trigger the fertility test market?
Which segment dominates the highest market share in the fertility test market?
What are the factors associated and responsible for the increasing maternal age?
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL FERTILITY TEST MARKET
EXHIBIT 2 GLOBAL FERTILITY TEST MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL BIRTH RATE PER WOMAN & ANNUAL % CHANGE 2000–2021
EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES IN MALE FERTILITY TESTS
EXHIBIT 5 IMPACT OF SMARTPHONE-BASED SAMPLE ANALYSIS
EXHIBIT 6 IMPACT OF INCREASING MATERNAL AGE
EXHIBIT 7 GLOBAL FEMALE LITERACY RATE 2015–2020 (%)
EXHIBIT 8 GLOBAL MATERNAL AGE RANGE 2011–2014 (%)
EXHIBIT 9 IMPACT OF SURGE IN INFERTILITY RATES WORLDWIDE
EXHIBIT 10 CAUSES & STATISTICS FOR INFERTILITY WORLDWIDE
EXHIBIT 11 CAUSES OF FEMALE INFERTILITY
EXHIBIT 12 IMPACT OF RISING AWARENESS OF FERTILITY TESTS
EXHIBIT 13 IMPACT OF LACK OF ACCURACY IN AVAILABLE FERTILITY TESTS
EXHIBIT 14 IMPACT OF LOW AWARENESS & ACCEPTANCE OF FERTILITY TESTS
EXHIBIT 15 GLOBAL FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 16 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY
EXHIBIT 17 GLOBAL FERTILITY TEST MARKET BY PRODUCTS
EXHIBIT 18 GLOBAL FERTILITY TEST MARKET BY GENDER
EXHIBIT 19 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL
EXHIBIT 20 GLOBAL FERTILITY TEST MARKET BY END USER
EXHIBIT 21 FIVE FORCES ANALYSIS 2021
EXHIBIT 22 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027
EXHIBIT 23 GLOBAL FERTILITY TEST MARKET BY PRODUCTS 2021-2027
EXHIBIT 24 GLOBAL FERTILITY TEST MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 25 GLOBAL FERTILITY TEST MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 26 MAJOR VENDORS SELLING OVULATION TEST KITS 2021
EXHIBIT 27 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 28 ADVANTAGES OF OVULATION TEST KITS
EXHIBIT 29 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS 2021–2027 ($ MILLION)
EXHIBIT 30 BEST-SELLING FERTILITY MONITOR KITS 2021
EXHIBIT 31 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021–2027 ($ MILLION)
EXHIBIT 33 CAUSES OF MALE INFERTILITY
EXHIBIT 34 MALE INFERTILITY RATE BY REGIONS
EXHIBIT 35 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS 2021–2027 ($ MILLION)
EXHIBIT 37 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 38 GLOBAL FERTILITY TEST MARKET BY GENDER 2021-2027
EXHIBIT 39 GLOBAL FERTILITY TEST MARKET BY GENDER: INCREMENTAL GROWTH
EXHIBIT 40 GLOBAL FERTILITY TEST MARKET BY GENDER: ABSOLUTE GROWTH
EXHIBIT 41 DECLINE IN FEMALE FERTILITY RATE BY REGION 1990–2019 (%)
EXHIBIT 42 FEMALE INFERTILITY RATE BY MATERNAL AGE GROUP (%)
EXHIBIT 43 GLOBAL FEMALE FERTILITY TEST MARKET: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL FEMALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 45 GLOBAL MALE FERTILITY TEST MARKET: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL MALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 48 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021–2027
EXHIBIT 49 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH
EXHIBIT 50 GLOBAL FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS 2021–2027 ($ MILLION)
EXHIBIT 53 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021–2027 ($ MILLION)
EXHIBIT 55 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021–2027 ($ MILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 58 GLOBAL FERTILITY TEST MARKET BY END USER 2021–2027
EXHIBIT 59 GLOBAL FERTILITY TEST MARKET BY END USER: INCREMENTAL GROWTH
EXHIBIT 60 TRENDS IN HOMECARE FERTILITY TEST PRODUCTS
EXHIBIT 61 GLOBAL FERTILITY TEST MARKET BY HOMECARE: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021–2027 ($ MILLION)
EXHIBIT 63 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021–2027 ($ MILLION)
EXHIBIT 65 GLOBAL FERTILITY TEST MARKET BY HOSPITALS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL FERTILITY TEST MARKET BY HOSPITALS 2021–2027 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 GLOBAL FERTILITY RATE 2021
EXHIBIT 69 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 70 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 71 GROWTH DRIVERS FOR NORTH AMERICA FERTILITY TEST MARKET
EXHIBIT 72 NORTH AMERICA FERTILITY TEST MARKET: KEY COUNTRIES (2020)
EXHIBIT 73 POPULATION AFFECTED BY INFERTILITY IN NORTH AMERICA 1984, 1992, & 2019 (%)
EXHIBIT 74 NORTH AMERICA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 75 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 76 US BIRTH RATE BY MATERNAL AGE (PER 1,000 WOMEN)
EXHIBIT 77 FERTILITY & PREGNANCY RELATED SUGGESTIONS BY DOCTORS IN US (%)
EXHIBIT 78 US FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 79 GROWTH DRIVERS FOR FERTILITY TESTS IN CANADA
EXHIBIT 80 AVERAGE FEMALE AGE DURING FIRST BIRTH IN CANADA (2012–2016)
EXHIBIT 81 FERTILITY RATE BY AGE GROUP IN CANADA 2016 (PER THOUSAND WOMEN)
EXHIBIT 82 CANADA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 83 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 85 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 86 INCREMENTAL GROWTH BY END USERS 2021 & 2027
EXHIBIT 87 FERTILITY RATE BY MATERNAL AGE GROUP IN EUROPE 2001, 2010, & 2019
EXHIBIT 88 KEY COUNTRIES IN EUROPE FERTILITY TEST MARKET 2020
EXHIBIT 89 EUROPE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 91 BIRTH RATE PER YEAR IN GERMANY 2016–2020
EXHIBIT 92 FERTILITY RATE IN GERMANY 2016–2020
EXHIBIT 93 GERMANY FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 94 FRANCE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 95 YEAR-ON-YEAR FERTILITY RATE IN ENGLAND & WALES 2011–2019
EXHIBIT 96 FERTILITY RATE IN UK BY AGE GROUP (LIVE BIRTHS PER 1000 WOMEN)
EXHIBIT 97 UK FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 98 ITALY FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 99 PREVALENCE OF INFERTILITY IN SPAIN
EXHIBIT 100 SPAIN FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 105 GROWTH DRIVERS FOR APAC FERTILITY TEST MARKET (BY COUNTRIES)
EXHIBIT 106 APAC FERTILITY TEST MARKET: KEY COUNTRIES (2020)
EXHIBIT 107 APAC FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 109 INFERTILITY STATISTICS IN CHINA
EXHIBIT 110 CHINA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 111 PROPORTION OF SUB-FERTILE JAPANESE COUPLES SEEKING FERTILITY TREATMENT BASED ON HOUSEHOLD INCOME (%)
EXHIBIT 112 JAPAN FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 113 FEMALE FERTILITY RATE IN INDIA (PER WOMAN) 2011–2021
EXHIBIT 114 INDIA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 CAUSES FOR INFERTILITY AMONG AUSTRALIAN COUPLES
EXHIBIT 116 AUSTRALIA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 117 DECLINE IN FERTILITY RATE ACROSS SOUTH KOREA 2013–2020
EXHIBIT 118 SOUTH KOREA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 119 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 123 LATIN AMERICA FERTILITY TEST MARKET: KEY COUNTRIES 2020
EXHIBIT 124 LATIN AMERICA FERTILITY TEST MARKET2021–2027 ($ MILLION)
EXHIBIT 125 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 126 FEMALE FERTILITY RATE IN BRAZIL 2017–2021
EXHIBIT 127 BIRTH RATE IN BRAZIL (PER WOMAN) 2005–2019
EXHIBIT 128 BRAZIL FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 129 BIRTH RATE IN MEXICO (PER WOMAN) 2009–2019
EXHIBIT 130 BIRTH RATE IN MEXICO (PER 1,000 WOMEN)
EXHIBIT 131 MEXICO FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 132 ARGENTINA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 133 INCREMENTAL GROWTH BY PRODUCTS 2021 & 2027
EXHIBIT 134 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 135 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 137 MIDDLE EAST AFRICA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 138 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 139 TURKEY FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 140 FACTORS CAUSING INFERTILITY AMONG 31–40 FEMALE AGE GROUP IN SAUDI ARABIA
EXHIBIT 141 SAUDI ARABIA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 142 SOUTH AFRICA FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 143 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 144 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 145 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 146 INCREMENTAL GROWTH BY END USER 2021 & 2027
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KITS 2021–2027 ($ MILLION)
TABLE 4 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021–2027 ($ MILLION)
TABLE 5 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KITS 2021–2027 ($ MILLION)
TABLE 6 GLOBAL FEMALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
TABLE 7 GLOBAL MALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
TABLE 8 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNEL 2021–2027 ($ MILLION)
TABLE 9 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021–2027 ($ MILLION)
TABLE 10 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021–2027 ($ MILLION)
TABLE 11 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021–2027 ($ MILLION)
TABLE 12 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021–2027 ($ MILLION)
TABLE 13 GLOBAL FERTILITY TEST MARKET BY HOSPITALS 2021–2027 ($ MILLION) (GEOGRAPHY)
TABLE 14 AB ANALITICA: MAJOR PRODUCT OFFERINGS
TABLE 15 AVA AG: MAJOR PRODUCT OFFERINGS
TABLE 16 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 17 BABYSTART: MAJOR PRODUCT OFFERINGS
TABLE 18 BIOZHENA: MAJOR PRODUCT OFFERINGS
TABLE 19 CYCLOTEST: MAJOR PRODUCT OFFERINGS
TABLE 20 DNA DIAGNOSTICS CENTER: MAJOR PRODUCT OFFERINGS
TABLE 21 EXSEED HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 22 FERTILITY FOCUS: MAJOR PRODUCT OFFERINGS
TABLE 23 FEMOMETER: MAJOR PRODUCT OFFERINGS
TABLE 24 FAIRHAVEN HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 25 GERATHERM MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 26 GIVE LEGACY: MAJOR PRODUCT OFFERINGS
TABLE 27 HILIN LIFE PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 28 IXENSOR: MAJOR PRODUCT OFFERINGS
TABLE 29 LADY TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 30 LETSGETCHECKED: MAJOR PRODUCT OFFERINGS
TABLE 31 MEDICAL ELECTRONIC SYSTEM: MAJOR PRODUCT OFFERINGS
TABLE 32 MODERN FERTILITY: MAJOR PRODUCT OFFERINGS
TABLE 33 OOVA: MAJOR PRODUCT OFFERINGS
TABLE 34 PIRAMAL PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 35 PREMOM: MAJOR PRODUCT OFFERINGS
TABLE 36 QUANOVATE: MAJOR PRODUCT OFFERINGS
TABLE 37 RAIING MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 38 SAMPLYTICS TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 39 SWIMCOUNT: MAJOR PRODUCT OFFERINGS
TABLE 40 SWISS PRECISION DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 41 TECO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 42 YESMOM: MAJOR PRODUCT OFFERINGS
TABLE 43 VALLEY ELECTRONICS AG: MAJOR PRODUCT OFFERINGS
TABLE 44 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 45 NORTH AMERICA FERTILITY TEST MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 46 EUROPE FERTILITY TEST MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 47 APAC FERTILITY TEST MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 48 LATIN AMERICA FERTILITY TEST MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 49 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 50 NORTH AMERICA FERTILITY TEST MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 51 EUROPE FERTILITY TEST MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 52 APAC FERTILITY TEST MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 53 LATIN AMERICA FERTILITY TEST MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 54 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY GENDER 2021–2027 ($ MILLION)
TABLE 55 NORTH AMERICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 56 EUROPE FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 57 APAC FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 58 LATIN AMERICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021–2027 ($ MILLION)
TABLE 59 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021–2027 ($ MILLION)
TABLE 60 NORTH AMERICA FERTILITY TEST MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 61 EUROPE FERTILITY TEST MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 62 APAC FERTILITY TEST MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 63 LATIN AMERICA FERTILITY TEST MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA FERTILITY TEST MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 65 GLOBAL FERTILITY TEST MARKET BY OVULATION TEST KIT 2021–2027 ($ MILLION)
TABLE 66 GLOBAL FERTILITY TEST MARKET BY FERTILITY MONITORS 2021–2027 ($ MILLION)
TABLE 67 GLOBAL FERTILITY TEST MARKET BY SPERM TEST KIT 2021–2027 ($ MILLION)
TABLE 68 GLOBAL FEMALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
TABLE 69 GLOBAL MALE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
TABLE 70 GLOBAL FERTILITY TEST MARKET BY ONLINE SALES CHANNELS 2021–2027 ($ MILLION)
TABLE 71 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021–2027 ($ MILLION)
TABLE 72 GLOBAL FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021–2027 ($ MILLION)
TABLE 73 GLOBAL FERTILITY TEST MARKET BY HOMECARE 2021–2027 ($ MILLION)
TABLE 74 GLOBAL FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021–2027 ($ MILLION)
TABLE 75 GLOBAL FERTILITY TEST MARKET BY HOSPITAL 2021–2027 ($ MILLION)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
4.3.2 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
4.3.3 MARKET SEGMENTATION BY END USER:
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCES IN MALE FERTILITY TESTS
8.2 SMARTPHONE-BASED SAMPLE ANALYSIS
9 MARKET GROWTH ENABLERS
9.1 INCREASING MATERNAL AGE
9.2 SURGE IN INFERTILITY RATES WORLDWIDE
9.3 RISING AWARENESS OF FERTILITY TESTS
10 MARKET RESTRAINTS
10.1 LACK OF ACCURACY IN AVAILABLE FERTILITY TESTS
10.2 LOW AWARENESS & ACCEPTANCE OF FERTILITY TESTS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 MARKET SHARE BY GEOGRAPHY
11.2.2 MARKET SHARE BY PRODUCTS
11.2.3 MARKET SHARE BY GENDER
11.2.4 MARKET SHARE BY DISTRIBUTION CHANNEL
11.2.5 MARKET SHARE BY END USER
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCTS
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 OVULATION TEST KITS
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 MARKET BY GEOGRAPHY
12.4 FERTILITY MONITORS
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 MARKET BY GEOGRAPHY
12.5 SPERM TEST KITS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 MARKET BY GEOGRAPHY
13 GENDER
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 FEMALE
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 MALE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 DISTRIBUTION CHANNELS
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 ONLINE SALE CHANNELS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 RETAIL PHARMACIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 HOSPITAL PHARMACIES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 END USERS
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOMECARE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 SPECIALTY & FERILITY CLINICS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 HOSPITALS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
16.2.1 DECLINE IN GLOBAL FEMALE FERTILITY RATE (REDUCTION PER WOMAN)
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 KEY COUNTRIES
17.3.1 US: MARKET SIZE & FORECAST
17.3.2 CANADA: MARKET SIZE & FORECAST
17.4 PRODUCTS
17.5 GENDER
17.6 DISTRIBUTION CHANNEL
17.7 END USERS
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 KEY COUNTRIES
18.3.1 GERMANY: MARKET SIZE & FORECAST
18.3.2 FRANCE: MARKET SIZE & FORECAST
18.3.3 UK: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 SPAIN: MARKET SIZE & FORECAST
18.4 PRODUCTS
18.5 GENDER
18.6 DISTRIBUTION CHANNEL
18.7 END USER
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 KEY COUNTRIES
19.3.1 CHINA: MARKET SIZE & FORECAST
19.3.2 JAPAN: MARKET SIZE & FORECAST
19.3.3 INDIA: MARKET SIZE & FORECAST
19.3.4 AUSTRALIA: MARKET SIZE & FORECAST
19.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
19.4 PRODUCTS
19.5 GENDER
19.6 DISTRIBUTION CHANNEL
19.7 END USER
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 KEY COUNTRIES
20.3.1 BRAZIL: MARKET SIZE & FORECAST
20.3.2 MEXICO: MARKET SIZE & FORECAST
20.3.3 ARGENTINA: MARKET SIZE & FORECAST
20.4 PRODUCTS
20.5 GENDER
20.6 DISTRIBUTION CHANNEL
20.7 END USER
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 KEY COUNTRIES
21.3.1 TURKEY: MARKET SIZE & FORECAST
21.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21.4 PRODUCTS
21.5 GENDER
21.6 DISTRIBUTION CHANNEL
21.7 END USER
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
23 COMPANY PROFILES
23.1 AB ANALITICA
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 AVA AG
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 ADVACARE PHARMA
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 BABYSTART
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 BIOZHENA
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.6 CYCLOTEST
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.7 DNA DIAGNOSTICS CENTRE
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 EXSEED HEALTH
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERINGS
23.9 FERTILITY FOCUS
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 FEMOMETER
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 FAIRHAVEN HEALTH
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 GERATHERM MEDICAL AG
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 GIVE LEGACY
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
23.14 HILIN LIFE PRODUCTS
23.14.1 BUSINESS OVERVIEW
23.14.2 PRODUCT OFFERINGS
23.15 IXENSOR
23.15.1 BUSINESS OVERVIEW
23.15.2 PRODUCT OFFERINGS
23.16 LADY TECHNOLOGIES
23.16.1 BUSINESS OVERVIEW
23.16.2 PRODUCT OFFERINGS
23.17 LETSGETCHECKED
23.17.1 BUSINESS OVERVIEW
23.17.2 PRODUCT OFFERINGS
23.18 MEDICAL ELECTRONIC SYSTEM
23.18.1 BUSINESS OVERVIEW
23.18.2 PRODUCT OFFERINGS
23.19 MODERN FERTILITY
23.19.1 BUSINESS OVERVIEW
23.19.2 PRODUCT OFFERINGS
23.20 OOVA
23.20.1 BUSINESS OVERVIEW
23.20.2 PRODUCT OFFERINGS
23.21 PIRAMAL HEALTHCARE
23.21.1 BUSINESS OVERVIEW
23.21.2 PRODUCT OFFERINGS
23.22 PREMOM
23.22.1 BUSINESS OVERVIEW
23.22.2 PRODUCT OFFERINGS
23.23 QUANOVATE
23.23.1 BUSINESS OVERVIEW
23.24 RAIING MEDICAL
23.24.1 BUSINESS OVERVIEW
23.24.2 PRODUCT OFFERINGS
23.25 INITO (SAMPLYTICS TECHNOLOGIES)
23.25.1 BUSINESS OVERVIEW
23.25.2 PRODUCT OFFERINGS
23.26 SWIMCOUNT
23.26.1 BUSINESS OVERVIEW
23.26.2 PRODUCT OFFERINGS
23.27 SWISS PRECISION DIAGNOSTICS
23.27.1 BUSINESS OVERVIEW
23.27.2 PRODUCT OFFERINGS
23.28 TECO DIAGNOSTICS
23.28.1 BUSINESS OVERVIEW
23.28.2 PRODUCT OFFERINGS
23.29 YESMOM
23.29.1 BUSINESS OVERVIEW
23.29.2 PRODUCT OFFERINGS
23.30 VALLEY ELECTRONICS AG
23.30.1 BUSINESS OVERVIEW
23.30.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY GEOGRAPHY
25.1.1 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY
25.2 MARKET BY PRODUCTS
25.2.1 NORTH AMERICA: FERTILITY TEST MARKET BY PRODUCTS
25.2.2 EUROPE: FERTILITY TEST MARKET BY PRODUCT
25.2.3 APAC: FERTILITY TEST MARKET BY PRODUCTS
25.2.4 LATIN AMERICA: FERTILITY TEST MARKET BY PRODUCTS
25.2.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY PRODUCTS
25.3 MARKET BY GENDER
25.3.1 NORTH AMERICA: FERTILITY TEST MARKET BY GENDER
25.3.2 EUROPE: FERTILITY TEST MARKET BY GENDER
25.3.3 APAC: FERTILITY TEST MARKET BY GENDER
25.3.4 LATIN AMERICA: FERTILITY TEST MARKET BY GENDER
25.3.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY GENDER
25.4 MARKET BY DISTRIBUTION CHANNEL
25.4.1 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNELS
25.4.2 EUROPE: MARKET BY DSTRIBUTION CHANNELS
25.4.3 APAC: MARKET BY DISTRIBUTION CHANNELS
25.4.4 LATIN AMERICA: MARKET BY DSTRIBUTION CHANNELS
25.4.5 MIDDLE EAST & AFRICA: MARKET BY DSTRIBUTION CHANNELS
25.5 MARKET BY END USER
25.5.1 NORTH AMERICA: MARKET BY END USER
25.5.2 EUROPE: MARKET BY END USER
25.5.3 APAC: MARKET BY END USER
25.5.4 LATINAMERICA: MARKET BY END USER
25.5.5 MIDDLE EAST & AFRICA: MARKET BY END USER
25.6 MARKET BY GEOGRAPHY
25.6.1 OVULATION TEST KIT MARKET BY GEOGRAPHY
25.6.2 FERTILITY MONITORS MARKET BY GEOGRAPHY
25.6.3 SPERM TEST KIT MARKET BY GEOGRAPHY
25.6.4 FEMALE: MARKET BY GEOGRAPHY
25.6.5 MALE: MARKET BY GEOGRAPHY
25.6.6 ONLINE SALES CHANNELS: MARKET BY GEOGRAPHY
25.6.7 RETAIL PHARMACIES: MARKET BY GEOGRAPHY
25.6.8 HOSPITAL PHARMACIES: MARKET BY GEOGRAPHY
25.6.9 HOMECARE: MARKET BY GEOGRAPHY
25.6.10 SPECIALTY & FERTILITY CLINICS: MARKET BY GEOGRAPHY
25.6.11 HOSPITAL: MARKET BY GEOGRAPHY
26 APPENDIX
26.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the size and growth rate in the fertility test market during the forecast period?
Who are the key players in the fertility test market?
What are the major growth drivers that trigger the fertility test market?
Which segment dominates the highest market share in the fertility test market?
What are the factors associated and responsible for the increasing maternal age?
Other RELATED Reports
Infertility Treatment Market - Global Outlook and Forecast 2019-2024
Published : January 2020
 Market - Industry Outlook and Forecast 2021-2026-1625459165.png)
U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026
Published : July 2021
